IP-10 (Protein|Antibody|cDNA Clone|ELISA Kit)

All IP-10 reagents are produced in house and quality controlled, including 3 IP-10 Antibody, 41 IP-10 Gene, 3 IP-10 Protein, 3 IP-10 qPCR. All IP-10 reagents are ready to use.

Recombinant IP-10 proteins are expressed by Yeast, E. coli with fusion tags as C-His, Native.

IP-10antibodies are validated with different applications, which are ELISA.

IP-10cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each IP-10 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.

IP-10 Protein (3)

Species

IP-10 Protein, Rat, Recombinant (His Tag)

80057-R08Y

Expression host: Yeast

Rat CXCL10 / Crg-2 Protein 15916

IP-10 Protein, Human, Recombinant

10768-HNAE

Expression host: E. coli

Human CXCL10 / Crg-2 Protein 9101

IP-10 Protein, Mouse, Recombinant (His Tag)

50139-M08Y

Expression host: Yeast

Mouse CXCL10 / Crg-2 Protein 14953
Go

IP-10 Antibody (3)

Application
Clonality
Host

Anti-IP-10 Antibody

10768-R121

Application: ELISA

Clonality: MAb

Anti-IP-10 Antibody

10768-RP01

Application: ELISA

Clonality: PAb

Anti-IP-10 Antibody

10768-T16

Application: ELISA

Clonality: PAb

Go

IP-10 cDNA Clone (41)

Human
Rat
Mouse

IP-10 qPCR Primer (3)

CXCL10, also known as crg-2, is a chemokine of the CXC subfamily and ligand for the receptor CXCR3. CXC chemokines are particularly significant for leukocyte infiltration in inflammatory diseases. CXCL10 has a three-dimensional crystal structure. Its signaling is mediated by the g protein-coupled receptor CXCR3, which is expressed on activated T cells and plays an important role in directing the migration of T cells, especially during Th1 responses. Binding of CXCL10 to CXCR3 results in pleiotropic effects, including stimulation of monocytes, natural killer and T-cell migration, and modulation of adhesion molecule expression. It is chemotactic for monocytes and T-lymphocytes. CXCL10 can be secreted by several cell types in response to IFN-γ. Baseline pre-treatment plasma levels of CXCL10 are elevated in patients chronically infected with hepatitis C virus (HCV) of genotypes 1 or 4 who do not achieve a sustained viral response (SVR) after completion of antiviral therapy.

Immune Checkpoint   Immunotherapy   Cancer Immunotherapy   Targeted Therapy

Protein
Antibody
Gene
qPCR
Close